Protein design of novel immunotherapeutic drugs
antibodies - gene therapy - vaccines - cellular therapies - peptides
Schoeder Lab
at Leipzig University, Medical Faculty, Institute for Drug Discovery
antibodies - gene therapy - vaccines - cellular therapies - peptides
at Leipzig University, Medical Faculty, Institute for Drug Discovery
Our Research Interests
We use computational protein design including machine learning to design proteins with new functionalities. Through interchanging application of computational protein design and experimental validation, we design a new generation of protein drugs.Funding of the lab
We thank RosettaCommons, the state of Saxony, the Faculty of Medicine of Leipzig University, the Coalition for Epidemic Preparedness Innovations (CEPI), the ScaDS.AI and the DAAD for their contributions to our research.
We are part of the SFB1423 "Structural Dynamics of GPCR Signaling". Check it out here: research.uni-leipzig.de/sfb1423/
We are also part of SFB1664 "SNP2PROT - Plant Proteoform Diversity". Link to SNP2PROT
clara.schoeder[at]medizin.uni-leipzig.de
Leipzig University Medical FacultyInstitute for Drug DiscoveryLiebigstr. 19D-04103 Leipzig